Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma
Clinical trial NCT07241546 · RECRUITING
Trial details
- NCT number
- NCT07241546
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-30
- Primary completion
- 2027-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.